<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>safety concerns on FinanClub</title>
    <link>https://finan.club/tags/safety-concerns/</link>
    <description>Recent content in safety concerns on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Sat, 12 Aug 2023 07:01:13 +0000</lastBuildDate><atom:link href="https://finan.club/tags/safety-concerns/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>EBAY</title>
      <link>https://finan.club/us/ebay/</link>
      <pubDate>Sat, 12 Aug 2023 07:01:13 +0000</pubDate>
      
      <guid>https://finan.club/us/ebay/</guid>
      <description>score:31
Chances: Analysis of eBay&amp;rsquo;s intrinsic value using GuruFocus&amp;rsquo; valuation method. Discovery of alarms failing to detect deadly gas, raising safety concerns. Exploration of the thrift store experience and its impact on consumer sentiment. Examination of self-made female billionaires under 50, including their business success.</description>
    </item>
    
    <item>
      <title>CSX</title>
      <link>https://finan.club/us/csx/</link>
      <pubDate>Sat, 12 Aug 2023 06:22:54 +0000</pubDate>
      
      <guid>https://finan.club/us/csx/</guid>
      <description>score:74
Chances: CSX Corp. is addressing the Deutsche Bank 2023 Transportation Conference, indicating active participation in industry events and potential positive financial outlook. CSX is partnering with the International Association of Sheet Metal, Air, Rail and Transportation Workers to extend its conductor training program, which could enhance employee skills and operational efficiency.</description>
    </item>
    
    <item>
      <title>APLS</title>
      <link>https://finan.club/us/apls/</link>
      <pubDate>Sat, 12 Aug 2023 05:34:48 +0000</pubDate>
      
      <guid>https://finan.club/us/apls/</guid>
      <description>score:-69
Chances: Apellis Pharmaceuticals reported better-than-expected second-quarter 2023 results, indicating strong performance in its financials. Positive data on SYFOVRE&amp;rsquo;s reduction of nonsubfoveal GA lesion growth could reflect the potential effectiveness of Apellis&amp;rsquo; products. Equity awards granted to new employees could attract and incentivize talented individuals to join the company, contributing to its growth.</description>
    </item>
    
  </channel>
</rss>
